Cutler Group LP Deciphera Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Oct 26, 2021	SELL	$26.46 - $37.15 $264,600 - $371,500	-10,000 Reduced 80.0%	2,500 $127,000
Q2 2021 Jul 19, 2021	BUY	$32.73 - $47.95 $81,824 - $119,875	2,500 Added 25.0%	12,500 $186,000
Q1 2021 Apr 26, 2021	BUY	$40.39 - $56.73 $60,585 - $85,095	1,500 Added 17.65%	10,000 $151,000
Q4 2020 Jan 21, 2021	BUY	$51.77 - $66.18 $77,655 - $99,270	1,500 Added 21.43%	8,500 $83,000
Q3 2020 Oct 27, 2020	SELL	$43.8 - $58.16 $21,900 - $29,080	-500 Reduced 6.67%	7,000 $103,000
Q1 2020 May 07, 2020	SELL	$33.63 - $69.4 $1.21 Million - $2.49 Million	-35,900 Reduced 82.72%	7,500 $176,000
Q4 2019 Feb 06, 2020	BUY	$31.7 - $69.93 $1.34 Million - $2.97 Million	42,400 Added 4240.0%	43,400 $199,000
Q3 2019 Oct 28, 2019	SELL	$19.95 - $38.85 $17,955 - $34,965	-900 Reduced 47.37%	1,000 $0
Q2 2019 Aug 09, 2019	BUY	$21.05 - $26.21 $39,995 - $49,799	1,900 New	1,900 $6,000
Q1 2019 May 10, 2019	SELL	$20.65 - $29.55 $4,130 - $5,910	-200 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$19.08 - $36.14 $3,815 - $7,228	200 New	200 $0

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.